Oxford BioTherapeutics and C4X recognised in the 2026 edition of The Sunday Times 100 Tech
Two portfolio companies make The Sunday Times 100 Tech ranking.
News
Smartr365 Mortgage Technology Expansion
Smartr365 launches full mortgage submissions with Halifax
Oxford BioTherapeutics Signs Strategic Collaboration with GSK to Discover Novel Antibody-Based Cancer Therapeutics
Oxford BioTherapeutics has agreed a new research collaboration with GSK to identify novel cancer targets using its OGAP-Verify platform.
Wonderhood Studios produce Waitrose Christmas advert
Waitrose's 2025 Christmas advertising campaign is a four-minute festive romantic comedy short film called "The Perfect Gift," starring Keira Knightley alongside comedian Joe Wilkinson
Calculus successfully exits employee engagement platform Mo (Thanksbox Limited)
The exit has delivered up to a 1.8x return for Calculus investors. For the Calculus VCT, it generates an additional £1.53 million in cash for the portfolio.
Calculus invests £1.5m in Grateful to transform tips for frontline workers
Harrogate and London-based Grateful - the automated tip pooling and tronc platform - has raised £1.5 million ($2m) seed funding from Calculus Capital.
Calculus invests in Trogenix
Calculus invests as part of a £70million Series A financing to drive clinical development of therapies for hard to treat cancers.
Arecor Signs Landmark Co-Development and Financing Agreements to Advance AT278
Arecor partners with Sequel Med Tech on AT278 insulin and raises up to $11m from Ligand, accelerating Phase 2 readiness, extending cash runway to 2027, and positioning for next-generation diabetes care and significant shareholder value creation.
C4X Discovery Advances Oral α4β7 Candidate for Inflammatory Bowel Disease
Calculus portfolio company C4X Discovery selects a best-in-class oral IBD candidate, highlighting innovation and value creation in UK biotech.
Calculus backed Optalitix Expands Quote Platform to Power Reinsurance Pricing
Calculus portfolio company Optalitix, a leading insurtech innovator, has announced the expansion of its flagship pricing platform, Optalitix Quote, into the reinsurance market.
Calculus invests in EnsiliTech as part of £4.5M raise
Calculus has invested in EnsiliTech, a company revolutionising the transport of life-saving medicines.
VCT Annual General Meeting 2025
The Annual General Meeting (AGM) of Calculus VCT plc (the “Company”) will be held virtually at 3pm on 23rd of September 2025.
How WorkL Is Transforming Productivity
At Calculus Capital, managers of the Calculus VCT, the Calculus EIS Fund, and the Calculus Knowledge Intensive EIS Fund, we are proud to back WorkL, the employee engagement platform founded by Lord Mark Price, former Waitrose boss and UK trade minister.
Thank You For Being Part Of Our Journey – 25 Year Video
Oxford BioTherapeutics Reaches Milestone in Boehringer Ingelheim Partnership
Oxford BioTherapeutics advances third cancer drug with Boehringer amid treatment revolution.
Riff Raff Entertainment Produced Netflix Series Black Rabbit Due To Premiere In September
In collaboration with Netflix, Riff Raff’s latest project, series Black Rabbit, is set to premiere globally on 18 September 2025.
FISCAL Technologies Launches Major Software Update
FISCAL technologies has launched a significant software update aimed at transforming how finance teams manage supplier data and mitigate risk.
Laverock Therapeutics expands seed funding and announces key milestone progress
Laverock closes additional seed funding led by Calculus
Smartr365 Launches Full Mortgage Automation for NatWest
Calculus VCT and EIS Fund company Smartr365 launches full mortgage automation for Natwest
Calculus portfolio companies at Cannes Film Festival
Maven Screen Media and Brouhaha Entertainment
Oxford BioTherapeutics shortlisted for Life Sciences & Health Tech Company of the Year
After a year of significant progress for the Company, OBT has been shortlisted for the award.
Optalitix shortlisted for Digital Insurance Innovation of the Year
Optalitix have been shortlisted for an award at the British Insurance Awards 2025.
Wonderhood selected as Waitrose creative partner
Waitrose announce creative partner for 2025 summer campaigns.
Arctic Shores help to shape new recruitment landscape as CVs are eroded by AI
Arctic Shores featured in The Times.